Blog
What Investors Look For in Healthtech Software
Key Takeaways
- Raising healthtech capital differs fundamentally from consumer or B2B SaaS because investors demand clinical validity, regulatory strength, and a clear path to reimbursement.
- Investors fund "painkillers" that solve urgent clinical, operational, or financial problems, not "vitamins" that are merely nice to have.
- Define your market precisely with realistic TAM and SOM figures rather than inflating it to the entire multi-trillion-dollar healthcare industry.
- In healthtech, outcomes matter more than engagement, so you must prove impact with pilot studies, ROI data, and clinical validation.
- Scalable technical architecture is essential because investors are buying your future ability to grow from hundreds to millions of users.
1. The Problem: Is it Real, and Is it Big Enough?
Before an investor looks at your technology, they look at the problem you are solving. In healthtech, it is easy to fall into the trap of building a "solution in search of a problem." Investors are wary of cool technology that doesn't address a significant pain point.Get a FREE Audit
We'll perform a comprehensive SEO, AEO, GEO & CRO audit of your website — completely free — and show you exactly how to outrank your competitors.
Don't have a site yet? Get in touch →
The "Nice-to-Have" vs. "Need-to-Have" Test
Investors want to fund "painkillers," not "vitamins."- Vitamins: These are nice-to-have solutions. An app that helps generally healthy people track their water intake is a vitamin. It’s useful, but nobody’s life (or bottom line) depends on it.
- Painkillers: These solve urgent, burning problems. A platform that reduces hospital readmission rates for heart failure patients—thereby saving the hospital millions in penalties—is a painkiller.
Market Size and Addressable Market (TAM)
Even if the problem is real, is the market big enough to generate venture-scale returns? Venture capitalists (VCs) operate on a power-law dynamic; they need their winners to win big.- Total Addressable Market (TAM): This is the total revenue opportunity if you achieved 100% market share. In healthtech, be careful not to overinflate this. Don't say "healthcare is a $4 trillion industry, so our market is $4 trillion." Be specific. "Our market is the $5 billion spent annually on cardiology practice management software."
- Serviceable Obtainable Market (SOM): This is the portion of the market you can realistically capture. Investors want to see a clear path to capturing a meaningful slice of a large pie.
2. Evidence of Clinical Validity and Outcomes
In almost any other software sector, "user engagement" is the north star metric. In healthtech, engagement matters, but outcomes matter more. If you claim your software improves health, you need to prove it.Moving Beyond Anecdotes
"Patients love our app" is not enough. Attracting investors to healthtech requires data.- Pilot Studies: Have you run a pilot with a clinic or hospital? What were the results? Did A1C levels drop? Did patient adherence improve by 20%?
- White Papers and Peer Review: Early-stage startups may not have randomized controlled trials (RCTs), but having a clinical advisory board and white papers that validate your methodology builds immense credibility.
- ROI Data: For B2B sales, the outcome is often financial. Can you prove that for every $1 spent on your software, the customer saves $3?
3. Scalability and Technical Architecture
Investors are buying a piece of your future, not just your present. They need to know that your technology can grow from 100 users to 10 million without collapsing. This is where your approach to software design & development comes under the microscope.Technical Debt vs. scalable Infrastructure
Startups often incur technical debt to move fast. Investors understand this, but they want to see a plan for paying it down.- Cloud Architecture: Are you built on a scalable, secure cloud infrastructure (AWS, Azure, Google Cloud)?
- Interoperability: This is a huge buzzword for a reason. Can your software talk to others? If your growth strategy relies on integrating with 50 different hospitals, and each integration takes you 6 months of custom coding, you are not scalable. Investors look for API-first architectures and adherence to standards like FHIR (Fast Healthcare Interoperability Resources).
- Automation: How much of your onboarding process is manual? If you need to fly a team to a hospital for a week to deploy your software, your margins (and scalability) will suffer. Investors favor "low-touch" or automated deployment models.
AI and Machine Learning: The "Black Box" Problem
If you pitch "AI-powered" solutions, expect scrutiny. Investors are savvy enough to know the difference between a simple algorithm and true machine learning.- Data Moat: Do you have access to a unique proprietary dataset to train your models? If you are training your AI on public data sets, what stops a competitor from copying you?
- Explainability: In healthcare, "black box" AI (where you can't explain how the AI reached a conclusion) is a liability. Can your software explain why it recommended a certain diagnosis? This is crucial for regulatory approval and clinician trust.
4. Regulatory Strategy and Compliance
In many industries, regulation is an afterthought. In healthcare, it is a central pillar of your business model. Investors view regulatory compliance not just as a legal requirement, but as a barrier to entry that protects defensible businesses.HIPAA and Data Security
It goes without saying that your software must be HIPAA compliant (or GDPR compliant in Europe). But investors will dig deeper.- Security Culture: Do you have a Chief Information Security Officer (CISO) or a strong security consultant?
- Audit Trails: Can you demonstrate robust audit logs and access controls?
- Business Associate Agreements (BAAs): Do you have the proper legal frameworks in place with your vendors and customers?
FDA and Reimbursement Pathways
If your software acts as a medical device (SaMD), do you have a clear regulatory strategy?- FDA Clearance: Do you know if you need 510(k) clearance? How long will that take, and how much will it cost? Investors need to factor this timeline into their funding run rate.
- Reimbursement: Who pays? This is the million-dollar question. Is there a CPT code that doctors can use to bill insurance for using your software? If not, you are relying on patients paying out-of-pocket or hospitals paying from their operational budget—both of which are harder paths to scale. Having a clear reimbursement strategy is often the difference between a "pass" and a term sheet.
5. User Adoption and Engagement (The Workflow Test)
The graveyard of digital health is filled with apps that had great clinical potential but terrible user experience (UX). Investors know that if doctors hate using your software, they won't use it.Seamless Workflow Integration
The biggest competitor to healthtech software is often the fax machine or the post-it note.- EHR Integration: Does your software require a doctor to log out of their Electronic Health Record (Epic, Cerner) and log into your portal? That is a friction point that kills adoption. Investors look for seamless integration where your tool lives inside the existing clinical workflow.
- Time Savings: Does your tool save time or add clicks? A tool that improves outcomes but adds 5 minutes to a patient visit is a hard sell. A tool that improves outcomes and saves 2 minutes is a unicorn.
Patient Engagement Metrics
For patient-facing apps, investors look at retention. Healthcare apps notoriously have high churn rates. People stop using them once they feel better.- Long-term Retention: Do users stick around after 30, 60, or 90 days?
- Daily Active Users (DAU) / Monthly Active Users (MAU): While this is a standard tech metric, in healthcare, the context matters. Frequent usage isn't always good (e.g., you don't want someone to need your urgent care app every day). Investors look for engagement patterns that match the clinical intent of the app.
6. The Business Model: Who Pays?
Healthcare has a unique "payer-provider-patient" triangle. The person using the app (patient) is rarely the person paying for it. Investors need to see that you have cracked the code on monetization.B2B vs. B2C vs. B2B2C
- Direct-to-Consumer (DTC): Hard to scale because customer acquisition costs (CAC) are high and retention is low. Investors are often wary of DTC unless you have a very strong brand.
- B2B (Selling to Employers/Payers): A popular model. Employers want to lower healthcare costs for their employees. But the sales cycles are long (12-18 months). Investors need to see that you have the runway and sales expertise to survive these cycles.
- B2B (Selling to Health Systems): Very difficult. Hospitals have long procurement processes and tight budgets. However, once you are in, you are sticky. High barriers to entry, but high retention.
7. The Team: Experience and Empathy
Finally, investors invest in people. In healthtech, the "ideal" team composition is specific.The "Hacker, Hustler, Healer" Triad
A team of three 20-year-old coders might struggle to raise healthtech capital. Investors look for a balance of skills:- Technical Talent: Someone who can build secure, scalable software.
- Business Acumen: Someone who can sell complex enterprise contracts and navigate fundraising.
- Clinical Expertise: A Chief Medical Officer (CMO) or a strong clinical advisory board is essential. You need someone who speaks "doctor" and understands the realities of patient care.
Actionable Tips for Preparing Your Investor Pitch
Knowing what investors look for is half the battle. The other half is presenting it effectively. Here are actionable steps to prepare your startup for fundraising.1. Build a Data Room Early
Due diligence in healthcare is brutal. Don't wait until an investor asks for documents. Build a virtual data room that includes:- IP assignment agreements.
- Regulatory correspondence (FDA letters, etc.).
- Clinical study results.
- HIPAA compliance documentation and security audits.
- Detailed financial models showing unit economics.
- Sales pipeline and contracts.
2. Know Your Unit Economics
Be prepared to answer tough questions about your business model.- CAC (Customer Acquisition Cost): How much does it cost to get a new doctor or patient on the platform?
- LTV (Lifetime Value): How much is that customer worth over time?
- Churn Rate: How many customers leave?
3. Sell the Vision, but Ground it in Reality
Your pitch deck needs to tell a compelling story. Paint the picture of the future where your software is the standard of care. But ground that vision in tangible milestones.- Bad: "We will revolutionize healthcare."
- Good: "We will reduce administrative burden for oncologists by 30% in the next 18 months, capturing 5% of the US market."
4. Leverage "Smart Money"
Not all money is equal. Look for investors who specialize in healthcare. A generalist tech investor might get scared off by FDA regulations or long sales cycles. A specialist healthtech investor understands these are features of the industry, not bugs. They can also open doors to hospital pilots and strategic partnerships.5. Validate Your Tech Stack
Before pitching, ensure your technical house is in order. If you claim your app is scalable but it crashes when 50 people log in, you are in trouble. Consider a technical audit. Partnering with experienced development firms for app design & development can ensure your architecture is investor-ready. Having a clean, documented codebase is a major asset during technical due diligence.Conclusion: Bridging the Gap Between Innovation and Investment
Raising capital for healthcare software funding is a rigorous process, and rightfully so. The products being built have the potential to save lives and reshape a fundamental human right. Investors act as gatekeepers, ensuring that only the most robust, compliant, and impactful solutions make it to the mainstream. For founders, the key is preparation. By focusing on clinical validity, ensuring regulatory compliance, building scalable technology, and demonstrating a deep understanding of the healthcare business model, you can position your startup as a prime investment opportunity. Remember, investors are looking for partners who can navigate the storm of healthcare complexity. Show them that you have the map, the vessel, and the crew to reach the destination. If you are preparing for a funding round and need to ensure your product is technically sound and visually compelling, we can help. Whether you need to refine your software design & development strategy or polish your MVP for a demo, contact us to learn how we can support your growth journey.Frequently Asked Questions
Why is raising money for healthtech harder than for other software startups?
Healthcare investors look beyond rapid user growth. They require clinical validity, regulatory fortitude, complex stakeholder alignment, and a viable path to reimbursement. Because moving fast and breaking things can cause lawsuits or patient harm rather than mere bugs, founders must speak investors' language, address their specific fears, and demonstrate deep understanding of the ecosystem's unique complexities.
What is the difference between a "painkiller" and a "vitamin" in healthtech?
A vitamin is a nice-to-have solution, like an app helping healthy people track water intake, that nobody depends on. A painkiller solves an urgent, burning problem, like a platform reducing hospital readmissions for heart failure patients and saving millions in penalties. Investors fund painkillers that address critical clinical problems, operational inefficiencies, or significant financial leaks.
How should I present my market size to healthtech investors?
Be specific rather than inflating your numbers. Avoid claiming the entire $4 trillion healthcare industry as your market. Instead, define a precise Total Addressable Market, such as the $5 billion spent annually on cardiology practice management software, and a realistic Serviceable Obtainable Market showing the meaningful slice you can actually capture.
What kind of evidence do investors want to see for clinical outcomes?
Anecdotes like "patients love our app" are insufficient. Investors want data: pilot studies with clinics showing measurable results such as dropped A1C levels or improved adherence, white papers and clinical advisory boards validating your methodology, and ROI data proving financial savings. They perform due diligence by calling the doctors and administrators actually using your product.
Why do investors care so much about scalability and technical architecture?
Investors are buying a piece of your future, not just your present. They need confidence that your technology can grow from 100 users to 10 million without collapsing. Venture capitalists operate on power-law dynamics and need their winners to win big, so a solid, scalable technical architecture is essential to delivering venture-scale returns.
Put this into action with eSEOspace
We help businesses grow with website development that actually performs. Explore the services behind this guide:
Get a FREE GEO/AEO/SEO Audit
We'll analyze your site's SEO, GEO, AEO & CRO — completely free — and show you exactly how to get found across Google and AI answers.
Don't have a site yet? Get in touch →
Great — your audit is on the way!
We'll send your free SEO/GEO/AEO/CRO audit within the next few hours. Where should we send it?
You're all set! ✓
Your free audit is being prepared — check your inbox in the next few hours. Talk soon!
On this page
- Key Takeaways
- 1. The Problem: Is it Real, and Is it Big Enough?
- 2. Evidence of Clinical Validity and Outcomes
- 3. Scalability and Technical Architecture
- 4. Regulatory Strategy and Compliance
- 5. User Adoption and Engagement (The Workflow Test)
- 6. The Business Model: Who Pays?
- 7. The Team: Experience and Empathy
- Actionable Tips for Preparing Your Investor Pitch
- Conclusion: Bridging the Gap Between Innovation and Investment
- Frequently Asked Questions
